Although a positive correlation was found between the IL-6 level and the proportion of CD56+ cells in the MS group (Figure 2d), we did not notice any difference in the CD56+ T cell content between healthy donors and COVID-19 patients. The gene discussed is NCAM1; the disease is COVID-19.